Ablation Of Premature Ventricular Complexes Research Articles

Selection of an impedance- or magnetic field-based electro-anatomical mapping platform does not affect outcomes of outflow tract premature ventricular complex manual ablation

Comparative data are virtually missing about the performance of different electro-anatomical mapping (EAM) system platforms on outflow tract (OT) premature ventricular complex (PVC) ablation outcomes with manual ablation catheters. We aimed to compare the acute success-, complication-, and long-term recurrence rates of impedance-based (IMP) and magnetic field-based (MAG) EAM platforms in manual OT PVC ablation. Single-centre, propensity score matched data of 39–39 patients ablated for OT PVCs in 2015–17 with IMP or MAG platforms were analysed. Acute success rate, peri-procedural complications, post-ablation daily PVC burden, and long-term recurrence rates were compared on intention-to-treat basis. Acute success rate was similar in the IMP and MAG group (77 vs. 82%, p = 0.78). There was a single case of femoral pseudo-aneurysm and no cardiac tamponade occurred. PVC burden fell significantly from baseline 24.0% [15.0–30.0%] to 3.3% [0.25–10.5%] (p < 0.001) post-ablation, with no difference between EAM platforms (IMP: 2.6% [0.5–12.0%] vs. MAG: 4.0% [2.0–6.5%]; p = 0.60). There was no significant difference in recurrence-free survival of the intention-to-treat cohort of the IMP and MAG groups (54 vs. 60%, p = 0.82, respectively) during 12 months of follow-up. Ablation with the aid of both impedance- and magnetic field-based EAM platforms can considerably reduce OT PVC burden and give similar acute- and long-term freedom from arrhythmia.

Ablation of parahisian premature ventricular complex from the noncoronary cusp.

Ablation of parahisian premature ventricular complex from the noncoronary cusp.

When to Consider Ablation for Premature Ventricular Complexes?

Premature ventricular complexes (PVCs) are a common rhythm disorder. Clinical manifestations range from no symptoms to debilitating symptoms that interfere with daily life. PVC-induced cardiomyopathy is a reversible condition in which left ventricular dysfunction is induced by a high PVC burden (usually > 10%). Management depends on symptoms, PVC burden, and presence or absence of structural heart disease. Catheter ablation is considered superior to medical therapy to suppress PVCs. PVC ablation should be considered in patients with symptomatic PVC and failed medical treatment, in patients with suspected PVC-induced cardiomyopathy, and for the treatment of PVC-triggered ventricular fibrillation (VF).

Left atrial functions in long term after catheter ablation of premature ventricular complexes.

Premature ventricular complex (PVC) ablation has been shown to improve left ventricle (LV) diastolic function and left atrial (LA) reverse modeling, especially in the short term. In the present study, PVC ablation via radiofrequency catheter (RFCA) was evaluated with respect to its long-term effects on LA size and dynamic functions. A total of 71 patients (age 43.49±12.8 years, 37 men [52%]) with high-burden (21% mean burden) PVCs who were treated with RFCA were included in this retrospective study. The effects of RFCA on three characteristics - LV systolic functions, LV diastolic dysfunctions and mechanical effects pertaining to the LA - were examined by echocardiography at baseline and at 3 months and 18 months after the procedure. Advancement in LV ejection fraction (LVEF) was seen on long-term follow-up (LVEF baseline 53.01; 3rd month 54.55; 18th month 58.02; p<0.001). LA function gradually improved after RFCA. The LA volume index was significantly decreased after RFCA (baseline 18.15±2.89; 3 months 17.11±2.71; 18 months 16.67±2.61; p<0.001). The LA passive emptying fraction was still increasing over long-term follow-up (baseline 33.33; 3rd month 37.11; 18th month 40.91; p<0.001). In the present study, in patients with or without apparent cardiomyopathy, RFCA was shown to successfully eliminate PVCs and improve LA functions in the long term.

Premature ventricular complex site of origin and ablation outcomes in patients with diabetes mellitus.

Premature ventricular complexes (PVCs) are frequent in patients with diabetes mellitus (DM). Still, the PVCs characteristics as well as the outcomes after catheter ablation in this population remain unknown. Aim of the study was to describe principal features of PVCs ablated in a wide DM-patients cohort and report postablation clinical outcomes in the follow-up of patients with DM and left ventricular dysfunction. From April 2012 to April 2020 data of 544 patients (315 [58%] men, 55±16 y), consecutive patients submitted for PVC ablation, were prospectively collected. Patients with left ventricle (LV) systolic disfunction (LVEF<50%) were included in a prospective protocol and followed at 6 and 12 months, and annually thereafter. Baseline characteristic as well ablation outcomes were analyzed based on the presence of DM. Sixty (11%) patients had DM. Patients with DM more frequently had a PVC's site of origin (SOO) in the LV (45 [75%] vs. 229 [48%], P<0.001). The most frequent PVC's SOO in DM patients was the LV outflow tract (OT) (35 [58%] patients: 12 aortic cusps; 12 LV summit; 11 in the myocardium immediately inferior to the valvular plane). Fifty-five (92%) patients with DM had an acute successful ablation, without differences compared with patients without DM (55 [92%] vs. 437 [90%], P=0.9). Twenty-tree (38%) DM-patients had LV dysfunction at the ablation time. In these patients, mean PVC burden decreased from 26±11% at baseline to 4±5% (P<0.001); LVEF increased from 36±8% to 42±11% (P<0.01) and NYHA class improved from 2.2±0.6 to 1.8+0.5 (P<0.01), after a mean follow-up of 37±14 months. Patients with DM frequently have PVC with a LV-SOO, being the LVOT the most frequent SOO in this population. Among DM patients with LV dysfunction, ablation persistently and significantly reduce the PVC burden improving functional status. Patients with DM have lower benefit in terms of LV function recovery after ablation compared with non-diabetic patients.

Characteristics and outcomes of ventricular tachycardia and premature ventricular contractions ablation in patients with prior mitral valve surgery.

Data regarding ventricular tachycardia (VT) or premature ventricular complex (PVC) ablation following mitral valve surgery (MVS) is limited. Catheter ablation (CA) can be challenging given perivalvular substrate in the setting of mitral annuloplasty or prosthetic valves. To investigate the characteristics, safety, and outcomes of radiofrequency CA in patients with prior MVS and ventricular arrhythmias (VA). We identified consecutive patients with prior MVS who underwent CA for VT or PVC between January 2013 and December 2018. We investigated the mechanism of arrhythmia, ablation approach, peri-operative complications, and outcomes. In our cohort, 31 patients (77% men, mean age 62.3 ± 10.8 years, left ventricular ejection fraction 39.2 ± 13.9%) with prior MVS underwent CA (16 VT; 15 PVC). Access to the left ventricle was via transseptal approach in 17 patients, and a retrograde aortic approach was used in 13 patients. A combined transseptal and retrograde aortic approach was used in one patient, and a percutaneous epicardial approach was combined with trans-septal approach in one patient. Heterogenous scar regions were present in 94% of VT patients and scar-related reentry was the dominant mechanism of VT. Forty-seven percent of PVC patients had abnormal substrate at the site targeted for ablation. Clinical VA substrates involved the peri-mitral area in six patients with VT and five patients with PVC ablation. No procedure-related complications were reported. The overall recurrence-free rate at 1-year was 72.2%; 67% in the VT group and 78% in the PVC group. No arrhythmia-related death was documented on long-term follow-up. CA of VAs can be performed safely and effectively in patients with MVS.

Role of chronic continuous intravenous lidocaine in the clinical management of patients with malignant type 3 long QT syndrome.

Type 3 long QT syndrome (LQT3) is caused by pathogenic, gain-of-function variants in SCN5A leading to a prolonged action potential, ventricular ectopy, and torsades de pointes. Treatment options include pharmacotherapy, cardiac denervation, and/or device therapy. Rarely, patients with malignant LQT3 require cardiac transplantation. The purpose of this study was to evaluate the role of chronic continuous intravenous (IV) lidocaine as a therapeutic option for select patients with LQT3 refractory to standard therapy. We performed a retrospective review of patients evaluated and treated at Mayo Clinic and identified 4 of 161 patients with LQT3 (2.5%) who were refractory to standard therapies and therefore treated with IV lidocaine. There were 4 patients (2 female [50%]). The median age at first IV lidocaine infusion was 2 months (interquartile range 1.5-4.8 months), and the median cumulative duration on IV lidocaine was 11.5 months (interquartile range 8.7-17.8 months). The main indication for IV lidocaine in all patients was persistent ventricular arrhythmias. Before IV lidocaine, all patients received an implantable cardioverter-defibrillator, and while on intermittent IV lidocaine, all patients underwent bilateral cardiac sympathetic denervation. Additionally, 2 (50%) patients had cardiac ablation for premature ventricular complexes. In all patients, lidocaine infusion resulted in a significant reduction of LQT3-triggered cardiac events. The main side effects of IV lidocaine observed were dizziness (n= 2, 50%) and seizures (n = 2, 50%). During follow-up, 3 of 4 (75%) patients underwent orthotopic cardiac transplantation. The remaining patient continues to receive IV lidocaine bolus for rescue as needed. For patients with LQT3 who are refractory to standard treatment, chronic IV lidocaine infusion can be used as a potential "bridge to transplant."

A Case of Premature Ventricular Complexes from the Proximal Left Bundle Branch Successfully Ablated from the Right Coronary Cusp

Background: Premature ventricular complexes (PVCs) from the proximal left bundle branch (LBB) can be ablated in the left ventricular outflow tract but can easily damage normal conduction bundles. Here, we report a case of successful ablation of PVCs from the proximal LBB within the right coronary cusp (RCC). Case presentation: Our patient was a 70-year-old woman with PVCs from the proximal LBB that were successfully ablated via the RCC through radiofrequency catheter ablation with a 3D mapping system; she had a complication of incomplete right bundle branch block (RBBB) and remained asymptomatic during follow-up. Conclusion: The RCC provides an alternative approach for ablating PVCs originating from the proximal LBB, owing to the close relationship between the RCC and proximal LBB.

787 Ablation of the ventricular ectopic foci: a therapeutic option for dilated cardiomyopathy due to arrhythmic MVP

Abstract Aims A subset of patients with mitral valve prolapse (MVP) are affected by a still not well understood condition characterized by frequent ventricular arrhythmias (mostly originating from papillary muscles) and sudden cardiac death (SCD). It is called MVP malignant syndrome (MVP MS). In these patients, the high arrhythmic burden may lead to left ventricular (LV) dyssynchrony and dysfunction, determining a tachycardia-induced cardiomyopathy (TIC). Reduction in arrhythmic burden determines LV recovery and ejection fraction improvement and interrupts LV progressive dilatation. Methods and reports We report the case of a 52-year-old woman with MVP and family history of both MVP and SCD who was referred to our department for symptomatic extrasystoles and dyspnoea during exercise. Palpitations begun 11 years before: in that occasion she performed a 3-lead-ECG-Holter monitoring which documented 3457 ventricular extrasystoles. Transthoracic echocardiography (TTE) showed normal LV dimension and function and a myxomatous mitral valve with prolapse of both leaflets. At that time beta-blocker therapy was introduced, but soon suspended because of patient’s clinical intolerance (bradycardia and hypotension). Since then she was lost at follow-up for years, until symptoms worsened. When she came to our attention, TTE showed dilated and hypokinetic LV (ejection fraction was 38%, S2 wave at TDI was 6.4 cm/s and global longitudinal strain value was −13%). CMR was performed and confirmed TTE findings. Mitral-annulus disjunction was described in anterior, lateral, and posterior wall and late gadolinium enhancement analyses showed subendocardial fibrosis in correspondence of the posterior papillary muscle (PM) and in the mid-inferior wall. Holter monitoring enlightened a high arrhythmic burden with 24 065 premature ventricular complexes (PVCs) of two morphologies (right bundle branch block-like and −120° axis and right bundle branch block-like and −75° axis). During stress test, PVCs increased as the heart rate increased, resulting in bigeminism at peak exercise. Considering all these features, we hypothesized a case of MVP MS in which the high ventricular arrhythmic burden resulted in TIC. Any available pharmacological attempt to reduce arrhythmias failed. Transcatheter (TC) ablation of PVCs was then proposed. Electrophysiological study identified the inner part of the posterior papillary muscle implantation region and the antero-lateral basal wall as PVCs sites of origin. Radiofrequency ablation was performed in both sites. After the procedure, despite an incomplete suppression of the posterior PM focus, 12-lead 24-h Holter monitoring and TTE performed during the hospitalization showed a consistent arrhythmic burden reduction and LV function improvement. At 6 months from the procedure, symptoms improved and Holter monitoring showed 7515 PVCs with a 54% arrhythmic burden reduction compared with the presentation. TE showed lower LV end-diastolic volume and an increase in ejection fraction up to 47%; global longitudinal strain was −17% and TDI showed a S2 wave on lateral wall of 11 cm/s, confirming left ventricle improvement after the arrhythmic burden reduction. Conclusions Complete suppression of PMs PVCs with TC ablation is difficult to obtain, especially when the focus is in the inner part of the PM and TC ablation of ventricular arrhythmias in MVP patients has not yet demonstrated his efficacy in reducing SCD. Nevertheless, it should be taken into consideration to obtain at least PVCs reduction in patients with high arrhythmic burden leading to TIC.

Remote magnetic navigation compared to contemporary manual techniques for the catheter ablation of ventricular arrhythmias in structural heart disease

BackgroundThere are limited data comparing remote magnetic navigation (RMN) to contemporary techniques of manual-guided ventricular arrhythmia (VA) catheter ablation. ObjectivesWe compared acute and long-term outcomes of VA ablation guided by either RMN or contemporary manual techniques in patients with structural heart disease. MethodsFrom 2010–2019, 192 consecutive patients, with ischemic cardiomyopathy (ICM) or non-ischemic cardiomyopathy (NICM) underwent catheter ablation for sustained ventricular tachycardia (VT) or premature ventricular complexes (PVCs), using either RMN (n = 60) or manual (n = 132) guided techniques. Acute success and VA-free survival were compared. ResultsIn ICM, acute procedural success was comparable between the 2 techniques (manual 43.5% vs. RMN 29%, P = 0.11), as was VA-free survival (manual 83% vs. RMN 74%, P = 0.88), and survival free from cardiac transplantation and all-cause mortality (manual 88% vs. RMN 87%, P = 0.47), both at 12-months after final ablation. In NICM, manual compared to RMN guided, had superior acute procedural success (manual 46% vs. RMN 19%, P = 0.003) and VA-free survival 12-months after final ablation (manual 79% vs. RMN 41%, P = 0.004), but comparable survival free from cardiac transplantation and all-cause mortality 12-months after final ablation (manual 95% vs. RMN 90%, P = 0.52). Procedural duration was shorter in both subgroups undergoing manual guided ablation, whereas fluoroscopy dose and complication rates were comparable. ConclusionRMN provides similar outcomes to manual ablation in patients with ICM. In NICM however, acute success, and long-term VA-free survival was better with manual ablation. Prospective, multi-centre randomised trials comparing contemporary manual and RMN systems for VA catheter ablation are needed.

Catheter ablation of premature ventricular complexes associated with left ventricular false tendons.

Clinical studies have suggested that there is a significant correlation between left ventricular (LV) false tendon and premature ventricular complexes (PVCs). This study aimed to investigate the electrophysiological characteristics and the outcome of radiofrequency catheter ablation (RFCA) for this category of PVCs. From a total of 2284 patients with idiopathic PVCs who underwent catheter ablation at 6 institutions in China, intracardiac echocardiography (ICE) was used during the procedure in 346 cases; 10 patients (2.9%) with PVCs associated with false tendon were retrospectively reviewed and enrolled in the present study. Activation mapping and pace mapping were performed to localize the origin of PVCs. ICE was used in all patients. If the false tendon was directly visualized and identified, we attempted to identify the distinct relationship with the PVC origin. The PVCs were successfully eliminated by ablation in all patients. The target sites were confirmed to be related to false tendon. The origin of PVCs was located at the attachment of the false tendon to the papillary muscle, LV septum, or LV apex. At the target site, high-frequency Purkinje potentials were observed preceding local ventricular activation in 7 patients. LV false tendon can be associated with PVCs, which can be cured by RFCA. An ICE-guided electroanatomical approach should be considered to improve the safety and feasibility of this procedure.

Ablation with zero-fluoroscopy of premature ventricular complexes from aortic sinus cusps: A single-center experience.

BackgroundCatheter ablation of premature ventricular complexes from aortic sinus cusps (ASC‐PVC) is a complex procedure that conventionally requires coronary catheterization (CC) to localize coronary artery ostium (CAO). Little published information is available on the mapping and ablation with zero‐fluoroscopy (ZF) of ASC‐PVC. The aim of the study was to determine the efficacy and safety of ASC‐PVC ablation with a ZF approach guided by 3D intracardiac echocardiography integration in the electroanatomical mapping system (ICE 3D‐EAM).MethodsThis observational study included one patient cohort treated conventionally and another treated with ICE 3D‐EAM‐guided ZF ablation. Clinical, efficacy, and safety outcomes were evaluated acutely and at 3 months follow‐up.ResultsThe study included 21 patients with ASC‐PVC: 10 in the ZF group (age 49 ± 16 years, 60% males) and 11 in the control group (age 47 ± 15 years, 27% males). Fluoroscopy was not required for any patient in the ZF group. Acute success was obtained in 80% of the ZF group vs 55% of the control group (P = .36). The recurrence rate was 30% in the ZF group vs 27% in the control group (P = 1). One nonsevere complication was observed in the ZF group (P = .48).ConclusionsZF catheter ablation of ASC‐PVC guided by ICE 3D‐EAM is feasible, effective, and safe.

Differentiating the origin of outflow tract premature ventricular complexes using the QRS-right ventricular apex interval

Abstract Background For localization of outflow tract Premature ventricular complexes (PVCs) many ECG criteria have been proposed, however in some cases it is difficult to accurately localize the origin of PVCs using the surface ECG. Objective This study aims to study the relation between QRS-right ventricular apex interval and the origin of the outflow tract PVCs. Patients and Methods The study included 30 patients (27 female, age 37.20 ± 7.87, RVOT origin 18) referred for PVCs ablation and we measured the interval from the onset of the earliest QRS complex of premature ventricular contractions (PVCs) to the distal right ventricular apical signal, (the QRS-RVA interval) and correlated this interval with origin of outflow tract PVCs as identified by the successful ablation during the procedure. Results Compared to PVCs originating from RVOT, the QRS-RVA interval was significantly longer in PVCs originating from LVOT (67.33±7.56 for LVOT PVCs vs. 37.11±4.34 for RVOT PVCs, p &amp;lt; 0.001). Receiver operating characteristic (ROC) analysis showed that a QRSRVA interval ≥47 ms has a sensitivity, specificity, positive and negative predictive values of 100%, 100%, 100%, 100% respectively, for prediction of an LVOT origin of PVCs Conclusion The QRS-RVA interval is a simple and accurate criterion for differentiating the origin of outflow tract arrhythmia during electrophysiology study, A QRS-RVA interval ≥47 ms suggests an LVOT origin of PVCs.

Incidental Detection of a Rare Coronary Anomaly During Catheter Ablation for Premature Ventricular Complexes: All in One Coronary Ostium

Single coronary artery is a rare congenital anomaly associated with sudden cardiac death even though most of the cases are asymptomatic. Cardiac computerized tomography angiography plays an essential role in establishing the diagnosis of single coronary artery and designating the arterial course. Being aware of coronary anomaly is crucial in some cases scheduled for catheter ablation of premature ventricular complex neighboring to coronary arteries to prevent radiofrequency ablation related vascular injury.

Landing on the spot: Approaches to outflow tract PVCs; from ECG to EGMs to intracardiac echocardiography.

Premature ventricular complexes (PVCs) are increasingly recognized, as the use of ECG wearables becomes more widespread. In particular, PVCs arising from both the right ventricular outflow tract (RVOT) and left ventricular outflow tract (LVOT) comprise the majority of these arrhythmias and form a significant component of an electrophysiology practice. A keen understanding of the correlative anatomy of the outflow tracts, in addition to recognizing key ECG indices illustrating PVC sites of origin, are fundamental in preparing for a successful ablation. Patient selection, incorporating symptomatology, structural disease, and PVC burden can pose a challenge, though tools such as the ABC-VT risk score may help identify those patients with a higher risk of clinical deterioration. Utilizing intracardiac echocardiography to highlight salient anatomic features not visible with fluoroscopy allows for a more precise and safer ablation. Interpretation of intracardiac EGMs, and the careful examination for low amplitude highly fractionated pre-potentials, enhanced by the advent of new developed mapping/ablation catheters, remains crucial. Utilizing these tools will guide the electrophysiologist to an efficient and effective outflow tract PVC ablation.

Predictors of long-term success after catheter ablation of premature ventricular complexes.

Some patients have late recurrence after acutely successful radiofrequency catheter ablation (RFCA) of premature ventricular complexes (PVCs). The aim of this study was to evaluate predictors of long-term success following acutely successful PVC RFCA. We identified consecutive patients at our institution with frequent PVCs undergoing RFCA and reviewed procedural data and medical records. Acute success was defined as elimination of targeted PVCs for at least 30-min after RFCA. Long-term success was defined as absence of targeted PVCs during all follow-up visits and PVC-burden <5% on follow-up monitoring. Among 241 patients (mean age 57 ± 15 years, 58% male), 161 (66.8%) had long-term success with median follow-up of 17.7 (IQR, 12.2-29.8) months. Unadjusted predictors of late PVC recurrence were increasing age, diabetes mellitus and alcohol use, while female-sex, shorter ablation-time, right ventricular PVC-origin, single PVC morphology, and earliest bipolar activation ≥24 ms pre-QRS were predictors of long-term success. In multivariate-analysis, female-sex, single-PVC morphology and earliest-onset of PVC ≥ 24 ms pre-QRS were independent predictors for long-term success. The positive-predictive value of earliest-bipolar onset of PVC ≥ 24 ms pre-QRS for long-term success was 0.77 (p < .001). Negative-predictive value of PVC < 15 ms pre-QRS for long-term success was 0.86 (p = .003), suggesting that RFCA when the bipolar electrogram preceded QRS by <15 ms was unlikely to result in long-term success. Female-sex, single-PVC morphology, and earliest-onset of bipolar electrogram ≥24 ms pre-QRS were multivariable predictors of long-term success in patients with PVCs undergoing RFCA. RFCA at sites with local onset <15 ms pre-QRS are unlikely to be successful.

Impact of a predefined pacemapping protocol for ablation of infrequent premature ventricular complexes: a prospective, multicenter study

Abstract Funding Acknowledgements Type of funding sources: None. Background Pacemapping (PM) is a useful maneuver for aiding PVC ablation procedures, but its stand-alone clinical value when activation mapping is precluded is still to be defined. Objectives To analyze the clinical efficacy of a predefined PM protocol to be applied during low-burden premature ventricular complex (PVC) ablation procedures, regardless of their site of origin (SOO) and the presence of prior structural heart disease (SHD). Methods Prospective, non-randomized, multicenter study including 185 consecutive patients referred for a first PVC ablation. A predefined PM protocol was performed to guide ablation whenever a burden &amp;lt; 1 PVC/min was found after a 15-min waiting period, which precluded activation mapping. PM was performed using the PASO module of CARTO3 navigation system, obtaining a correlation grading, color-coded map. A minimum correlation of 94% was required for classifying an area as the PVC-SOO. After identifying the SOO, a high-density PM map with a fill threshold set to 6 was performed and ablation was delivered to the ‘target area’, defined as the area delimited by the 3 best matching points above the minimum correlation of 94%. Three RF applications were systematically applied in the target area with appropriate parameters: 40 W for the RVOT and aortic root, 50 W for the subvalvular LVOT, 20-30 W in the distal coronary sinus, at operator’s discretion in other locations. Clinical success was defined as a PVC-burden reduction of ≥ 80% in the 24-h Holter after 6 months. Results 105/185 patients (57%) could undergo activation mapping, while 60/185 (32%) had to be PM-guided. Only 20 patients (11%) had to be canceled due to complete absence of PVCs. Baseline QRS, PVC burden and an OT origin were independent predictors of the need to undergo a PM-guided ablation. The most frequent SOO locations were RVOT (44%), LV (23%), and LVOT (16%), with a significantly higher proportion of RVOT-SOO in the PM group (52% vs. 40%, p = 0.03). The mean target area was 0.6 ± 0.9 cm2, with a mean smallest PM correlation within that area of 95 ± 4%. The mean 10-ms isochronal area in LAT-guided procedures was significantly higher than the PM target area (1.7 ± 2.3 cm2; p &amp;lt; 0.001). The mean number of PM matching points acquired was 39 ± 21 (range 6 – 98). Mean mapping (29 ± 22 min) and RF (135 ± 124 sec) times were similar both for LAT and PM-guided procedures, with significantly shorter procedure times in the PM group (53 ± 24 vs. 61 ± 26 min; p = 0.04). Clinical success after a 6-month follow-up reached 87% for the PM approach, similar to that of LAT mapping-based ablation procedures (90%; p = 0.58). Conclusions When LAT mapping is precluded by a very low PVC burden in unselected patients referred for PVC ablation procedures, a first-line, stepwise PM and ablation protocol directed to a target area with &amp;gt; 94% matching correlation is a feasible alternative, reaching comparable clinical results regardless of the PVC-SOO and the presence of SHD. Abstract Figure. Example of a predefined PM protocol

Zero fluoroscopy PVC ablation

Abstract Funding Acknowledgements Type of funding sources: None. Premature ventricular complex(PVC) catheter ablation is required in a wide spectrum of the population.Ionizing radiation exposure in this procedure carries health risks,especially in young patients. In this prospective observational study we included 18 patients,submitted to PVC ablation without fluoroscopy between October 2018 and December 2020.Baseline characteristics of the population,acute success and complications derived from the procedure were evaluated,as well as recurrence rate during follow-up. Median age was 49.5 years. Most often cause of ablation were palpitations(77.8%),followed by reduced LVEF(16.7%) and dyspnoea(5.6%).33.3% had a cardiopathy,the most common was tachycardiomyopathy(66.7%).PVC burden pre-ablation was 25 ± 12.6%.The most frequent PVC origin was RVOT(66.7%)followed by LVOT(22.2%),mitral annulus(5.6%) and papillary muscles(5.6%). We used a 3D electroanatomical navigation system in all cases,intracardiac echocardiography in 88.9% and a contact force catheter for mapping(61%) and ablation(88.9%).The mean maximum radiofrequency power applied was 35 ± 5.7W(236.5s median time).Median number of applications was 5.5 and mean total procedural time was 198.6 ± 67.5 minutes.Median best prematurity was 28ms.We used isoprenaline in order to induce PVC in 77.8% of cases and suppression of PVC was achieved in 88.9%.There was only one complication(pericardial effusion without the need for pericardiocentesis).Median follow-up of 5 months,17.6% of recurrences(&amp;lt;80% reduction of PVC burden at 3 months),all them(3) from RVOT. In conclusion, the PVC ablation without fluoroscopy is a safe procedure with no major complications and good rates of success and recurrence in our experience. Baseline characteristics of the patientsMale6(33.3%)Female12(66.7%)Median age-yr.(range)49.5 (23-71)HTA6(33.3%)DM2(11.1%)Dyslipidemia3(16.7%)Smoking6(33.3%)LVEF median-(%)56.5%Treatment pre-ablationBeta blockers11(61.1%)No treatment6(33.3%)BB + flecainide/propafenone1(5.6%)1st column: Characteristics /2nd column: Patients included (N = 18) Abstract Figure 1

Predictors of adequate intraprocedural premature ventricular complex (pvc) frequency during idiopathic pvc ablation

Abstract Funding Acknowledgements Type of funding sources: None. Background The aim of the present study was to determine the predictors of adequate intraprocedural premature ventricular complex (PVC) frequency for successful mapping and ablation of idiopathic PVCs. Methods A total of 101 consecutive patients (45 men; age: 47.9 ± 14.2 years) who had undergone idiopathic PVC ablation between 01 November 2018 and 24 June 2020 constituted our study population. Clinical and demographic data, procedural details and 24 h rhythm recordings that had been recorded before the procedure were retrospectively evaluated. Total PVC burden and diurnal variability assessed by the ratio of night time (22:00–06:00) over day time (06:00–22:00) PVC burden was calculated. Patients were classified into three groups based on the relationship between hourly PVC number and HR. If there was a significant positive correlation between hourly PVC number and corresponding hourly HR, patients were classified into the fast HR-PVC group. If there was a significant negative correlation between hourly PVC number and corresponding hourly HR, patients were classified into the slow HR-PVC group. Patients were classified into the independent HR-PVC group if there was no significant correlation between hourly PVC number and corresponding hourly HR. Clinical characteristics and Holter parameters were compared between groups with and without adequate intraprocedural frequency of PVCs that permitted activation mapping. Results In all, 74 patients had frequent intraprocedural PVC that permitted activation mapping (Group 1) and 27 patients (26.7%) had infrequent intraprocedural PVCs which necessitated isoproterenol infusion or cancellation of ablation procedure (Group 2). PVC burden was significantly higher in the group with frequent intraprocedural PVCs (26.1 ± 9.4% vs 21.2 ± 10.3%; p: 0.026). There were no significant differences between groups regarding the relationship between hourly PVC number and heart rate (Fast HR-PVC 42 (56.8%) vs 18 (66.6%); slow HR-PVC 4(5.4%) vs 3 (11.1%); independent HR PVC 28 (37.8%) vs 6 (22.2%) in the respective order for group 1 and group 2; p: 0.26) or the ratio of night/day PVC burden (median 0.99 (IQR 0.4) vs median 0.83 (IQR 0.54) in the respective for group 1 and group 2 ; p: 0.53). Binary logistic regression analysis revealed the 24 h Holter PVC burden as the sole parameter that is significant predictor of frequent intraprocedural PVCs permitting activation mapping. A Holter PVC burden ≥ 19.43% had 72% sensitivity and 60% specificity for the prediction of sufficient intraprocedural PVCs that permitted activation mapping and ablation (area under the curve: 0.65; p: 0.02) Conclusion The 24 h PVC burden was the only predictor of adequate intraprocedural PVC frequency permitting activation mapping during idiopathic PVC ablation.

A Left sided site of origin is associated with adverse cardiovascular outcomes in patients with LV dysfunction undergoing PVC ablation

Abstract Funding Acknowledgements Type of funding sources: None. Background Epidemiological studies suggested that premature ventricular complexes (PVCs) are associated with cardiac mortality. But data are still inconclusive. Aim This study sought to analyze predictors of adverse outcomes in a population of patients with left ventricular (LV) systolic dysfunction who underwent PVC ablation. Methods 135 consecutive patients [100 (74%) men, 59 +12 y.o.] with LV systolic dysfunction [LV ejection fraction (LVEF) &amp;lt;50%] and frequent PVCs who underwent PVC ablation were included in a multicenter prospective international register. Patients were followed-up at 6 and 12 months and annually thereafter. The last evaluation performed was considered the long-term follow-up (LTFUP) evaluation. Cardiac mortality and/or cardiac transplantation and/or admission for heart failure was considered the primary endpoint. Results 82 (61%) patients had a left-sided PVC’s site of origin (LS-SOO), 51 (38%) had a right-sided SOO (RS-SOO) whereas SOO could not be determined in 2 (1%) patients. LS-SOO patients were older (61 ± 11 vs 52 ± 10, p &amp;lt; 0.001) more frequently men [71 (87%) vs 27 (53%), p &amp;lt; 0.001] with previous history of atrial fibrillation (AF) [14 (15%) vs 0, p = 0.001] and with a previously diagnosed structural heart disease (SHD) [43 (52%) vs 6 (11%), p &amp;lt; 0.001]. After a mean follow-up of 39 ± 21 months (range 24-94 months) there was a significant reduction in the PVC burden from 24 ± 13% at baseline to 4 ± 6% at LTFUP, p &amp;lt; 0.001; LVEF improved from 33 ± 8% at baseline to 41 ± 13% at LTFUP (p &amp;lt; 0.001) and NYHA class from 2.1 ± 0.6% to 1.4 ± 0.6% (p &amp;lt; 0.001); BNP levels decreased from 237 ± 231 pg/mL to 137 ± 185 pg/mL (p = 0.001). The primary end-point was reached in 10% patients (7 cardiac deaths, 1 cardiac transplantation and 5 heart failure admisions), 14,8% in LS-SOO and 1,9% in RS-SOO patients, log rank = 0.05 (Figure 1). Conclusions Among patients with LV dysfunction who underwent PVC ablation, those with LS-SOO were older and more frequently had AF and SHD. LS-SOO was associated with adverse cardiovascular outcomes. These findings suggest that PVCs with LS and RS-SOO should be considered as two different clinicals entities, with different prognostic values. Abstract Figure 1